Health Care Consolidation Sparks Innovation, Takeda CEO Says Following Mega-Deal
*By Chloe Aiello*
Consolidation in the health care industry won't necessarily raise drug prices, Takeda CEO Christophe Weber told Cheddar, one week after the Japanese pharmaceutical company Takeda acquired Ireland-based drugmaker Shire for north of $50 billion.
"We spend around $4 billion per year in \[research and development\] and you need a lot of financial muscle for that. That is really what's behind the scale. You are looking for scale to finance R&D. The higher your productivity, the more flexible you will be on the pricing," Weber said.
The acquisition of Shire is the largest foreign buy-out ever executed by a Japanese firm, according to [The Economist](https://www.economist.com/business/2018/12/08/takedas-acquisition-of-shire-is-japans-biggest-ever-foreign-takeover), and makes Takeda one of the world's largest drug producers. The acquisition gives Takeda greater access to the U.S. market ー it listed on the New York Stock Exchange earlier this monthー as well as to a slate of new drugs in development. Post-merger, the new company is focusing on four different disease types ー gastroenterology, oncology, neuroscience, and rare disease ー and has 21 new drugs in late-stage development.
"It's exciting for us," Weber said.
Consolidation, especially in the expensive U.S. health care system, always invites scrutiny and concern over further hikes. Even political opposites like President Trump and Sen. Elizabeth Warren (D-Mass.) have slammed drug company executives for the high cost of drugs using similar language. Trump has accused pharmaceutical companies of ["getting away with murder"](https://www.reuters.com/article/us-usa-trump-drugpricing/trump-says-pharma-getting-away-with-murder-stocks-slide-idUSKBN14V24J), while Warren said they are "raking in profits on the backs of patients."
Weber acknowledged that competition is one key to price stabilization in health care, but said rather than contribute to price hikes, his new mega-company will leverage its size to finance research.
"The issue is R&D costs a fortune, and that's why medicines are expensive ー it's because R&D is so expensive. That's really the issue. So we need to work on better productivity, better R&D productivity. We have developed a unique R&D model, I believe, in the company and that's what will give us flexibility in the future," Weber said.
Weber said he sees a future role for technology and biotech companies in health care. They can contribute to innovations ー like gene therapy, for example ー and data collection.
"We need more real-life data, how is a patient doing instead of just clinical trial data, so this is where the tech can help to generate more of this data," Weber said.
For full interview [click here](https://cheddar.com/videos/takeda-ceo-vows-responsible-pricing-after-mega-pharmaceutical-merger).
At 100 years old, the Goodyear Blimp is an ageless star in the sky. The 246-foot-long airship will be in the background of the Daytona 500 — flying roughly 1,500 feet above Daytona International Speedway, actually — to celebrate its greatest anniversary tour. Even though remote camera technologies are improving regularly and changing the landscape of aerial footage, the blimp continues to carve out a niche. At Daytona, with the usual 40-car field racing around a 2½-mile superspeedway, views from the blimp aptly provide the scope of the event.
You'll just have to wait for interest rates (and prices) to go down. Plus, this deal's a steel, the big carmaker wedding is off, and bribery is back, baby!
It’s a chicken-and-egg problem: Restaurants are struggling with record-high U.S. egg prices, but their omelets, scrambles and huevos rancheros may be part of the problem. Breakfast is booming at U.S. eateries. First Watch, a restaurant chain that serves breakfast, brunch and lunch, nearly quadrupled its locations over the past decade to 570. Fast-food chains like Starbucks and Wendy's added more egg-filled breakfast items. In normal times, egg producers could meet the demand. But a bird flu outbreak that has forced them to slaughter their flocks is making supplies scarcer and pushing up prices. Some restaurants like Waffle House have added a surcharge to offset their costs.
William Falcon, CEO and Founder of Lightning AI, discusses the ongoing feud between Elon Musk and Sam Altman, and how everyday people can use AI in their lives.
U.S. tariffs on steel and aluminum “will not go unanswered,” European Union chief Ursula von der Leyen vowed on Tuesday, adding that they will trigger toug
The Trump administration has ordered the Consumer Financial Protection Bureau to stop nearly all its work, effectively shutting down the agency that was created to protect consumers after the 2008 financial crisis and subprime mortgage-lending scandal. Russell Vought is the newly installed director of the Office of Management and Budget. Vought directed the CFPB in a Saturday night email to stop work on proposed rules, to suspend the effective dates on any rules that were finalized but not yet effective, and to stop investigative work and not begin any new investigations. The agency has been a target of conservatives since President Barack Obama created it following the 2007-2008 financial crisis.
